Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Prostate Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: ORIC Pharmaceuticals, Yale University.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Prostate Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.
Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.